These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2718057)

  • 21. Current techniques of hyperthermic isolated limb perfusion for malignant melanoma.
    Tominaga R; Kohno H; Mayumi H; Shiraishi K; Nagae S; Nakayama J; Yasui H
    Surg Today; 2000; 30(4):339-42. PubMed ID: 10795866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Locoregional recurrence of melanomas of the extremities after hyperthermic extremity perfusion: is reperfusion of value?].
    Meyer T; Göhl J; Hohenberger W
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1452-4. PubMed ID: 9931909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Blood changes in hyperthermic perfusion with chemotherapeutic preparations].
    Voronko EA; Fradkin SZ
    Vopr Onkol; 1974; 20(1):98. PubMed ID: 4216151
    [No Abstract]   [Full Text] [Related]  

  • 24. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
    Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
    Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.
    Vrouenraets BC; Eggermont AM; Hart AA; Klaase JM; van Geel AN; Nieweg OE; Kroon BB
    Eur J Surg Oncol; 2001 Jun; 27(4):390-5. PubMed ID: 11417986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.
    Lejeune FJ; Eggermont AM
    J Clin Oncol; 2007 Apr; 25(11):1449-50; author reply 1450-1. PubMed ID: 17416870
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dye dilution test to determine leakage during regional perfusion in the treatment of malignant tumors of the extremities].
    Ghussen F; Isselhard W; Sturz J; Welte CP; Stock W; Müller EW
    Chir Forum Exp Klin Forsch; 1979; ():165-8. PubMed ID: 378584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolated regional limb hyperthermic perfusion as treatment for melanoma.
    Loescher LJ; Leigh S
    Cancer Nurs; 1984 Dec; 7(6):461-7. PubMed ID: 6568866
    [No Abstract]   [Full Text] [Related]  

  • 29. Hyperthermia and chemotherapy by regional perfusion for tumors of the extremities.
    Cavaliere R; Di Filippo F; Moricca G; Santori F; Varanese A; Cavallari A; Carlini S; Brunori M; Aloe L; Monticelli G
    Prog Clin Biol Res; 1982; 107():775-92. PubMed ID: 6962956
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hyperthermic regional perfusion in malignant melanoma of an extremity].
    Andersson AP; Drzewiecki KT
    Ugeskr Laeger; 1992 Oct; 154(41):2815-9. PubMed ID: 1413222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Randomized melanoma study of perfusion of the extremities. Results of treatment 2 1/2 years after premature discontinuation].
    Ghussen F; Krüger I; Groth W; Stützer H
    Chirurg; 1986 Oct; 57(10):619-23. PubMed ID: 3539548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion.
    Testori A; Verhoef C; Kroon HM; Pennacchioli E; Faries MB; Eggermont AM; Thompson JF
    J Surg Oncol; 2011 Sep; 104(4):397-404. PubMed ID: 21858835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy.
    Lehti PM; Moseley HS; Janoff K; Stevens K; Fletcher WS
    Surg Gynecol Obstet; 1986 Feb; 162(2):149-52. PubMed ID: 3945892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of isolated limb perfusion to manage recurrent malignant melanoma.
    Ma D; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):441-50, ix. PubMed ID: 10941564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities.
    Sanki A; Kroon HM; Kam PC; Thompson JF
    Curr Probl Surg; 2011 Jun; 48(6):371-430. PubMed ID: 21549235
    [No Abstract]   [Full Text] [Related]  

  • 36. FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma.
    van Ginkel RJ; Hoekstra HJ; Pruim J; Nieweg OE; Molenaar WM; Paans AM; Willemsen AT; Vaalburg W; Koops HS
    J Nucl Med; 1996 Jun; 37(6):984-90. PubMed ID: 8683328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated regional therapy for advanced extremity soft tissue sarcomas.
    Deneve JL; Zager JS
    Surg Oncol Clin N Am; 2012 Apr; 21(2):287-99. PubMed ID: 22365520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
    Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated limb infusion for melanoma: a less morbid alternative to hyperthermic isolated limb perfusion in the US.
    Santillan AA; Zager JS
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1033-7. PubMed ID: 20078252
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intraoperative (hyperthermic) intraperitoneal chemotherapy--considerations and aspects of safe intra- and postoperative treatment with cytostatic drugs].
    Jähne J; Piso P; Schmoll E; Haulitschek-Hauss R; Sterzenbach H; Paul H; Pichlmayr R
    Langenbecks Arch Chir; 1997; 382(1):8-14. PubMed ID: 9157234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.